Screener
Lexaria Bioscience LEXX Q4 2025 earnings
Reported January 13, 2026 · Before market open
EPS-$0.07Beat by $0.06
Revenue estimate$100.0K
EPS estimate-$0.13
Next report
Oct 28, 2026 (in 2 months)Revenue estimate$50.0K
EPS estimate-$0.90
Versus estimates
FAQ
- When did Lexaria Bioscience report Q4 2025 earnings?
- Lexaria Bioscience (LEXX) reported Q4 2025 earnings on January 13, 2026 before market open.
- What were Lexaria Bioscience's Q4 2025 revenue and EPS?
- Lexaria Bioscience reported eps of $-0.07 for Q4 2025.
- Did Lexaria Bioscience beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.13 by $0.06.
- How did Lexaria Bioscience's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 56.3% from $-0.16.
- Where can I find Lexaria Bioscience's Q4 2025 SEC filings?
- You can read the 10-Q periodic report (0001640334-26-000080) directly on SEC EDGAR. The filing index links above go to sec.gov.
